Tevogen Bio Holdings Inc. (TVGN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $406.59M
Last updated: Nov 17, 2026 at 3:04 AM ET
Tevogen Bio Holdings Inc. (TVGN) Competitors
The companies most similar to Tevogen Bio Holdings are Regenxbio (RGNX), Tectonic Therapeutic (TECX) and Neurogene (NGNE). By market cap, Tevogen Bio Holdings ranks 10th of the 13 companies on this page; Entera Bio (ENTX) is the largest at $541.57M.
Peer Comparison
TVGN's ROIC of 2022.8% is above the peer median of -38.3%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Tevogen Bio Holdings (TVGN) | $406.59M | N/A | N/A | 0.0% | 2022.8% | 0.0% | 0.00% |
| Regenxbio Inc (RGNX) | $505.18M | N/A | 3.1x | -113.9% | N/A | -69.2% | 0.00% |
| Tectonic Therapeutic, Inc. (TECX) | $413.27M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Neurogene Inc (NGNE) | $495.37M | N/A | N/A | 0.0% | -28.5% | 0.0% | 0.00% |
| Zevra Therapeutics Inc. (ZVRA) | $540.30M | 11.6x | 3.7x | 52.8% | N/A | 44.9% | 0.00% |
| Ovid Therapeutics Inc (OVID) | $479.38M | N/A | 335.8x | 0.0% | N/A | -88.3% | 0.00% |
| PepGen Ltd (PEPG) | $410.98M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Prothena Corporation plc (PRTA) | $419.01M | N/A | 7.8x | -45.4% | N/A | -74.3% | 0.00% |
| Inovio Pharmaceuticals Inc (INO) | $267.85M | N/A | 462.0x | 0.0% | N/A | -100.0% | 0.00% |
| Kyverna Therapeutics, Inc. Common Stock (KYTX) | $319.27M | N/A | N/A | 0.0% | -81.5% | 0.0% | 0.00% |
| Candel Therapeutics Inc (CADL) | $486.37M | N/A | N/A | 0.0% | -43.5% | 0.0% | 0.00% |
| Entera Bio Ltd (ENTX) | $541.57M | N/A | N/A | 0.0% | -8.5% | -100.0% | 0.00% |
| Precision BioSciences Inc (DTIL) | $288.76M | N/A | 4.4x | -85.6% | -38.3% | 37272.0% | 0.00% |
| Peer median | $449.20M | 11.6x | 6.1x | 0.0% | -38.3% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Tevogen Bio Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Regenxbio Inc (RGNX) | REGENXBIO Inc., a clinical-stage biotechnology company, offers candidate gene therapy products to deliver genes to cells to address genetic defects or to enable... | RGNX competitors |
| Tectonic Therapeutic, Inc. (TECX) | Tectonic Therapeutic, Inc. engages in the discovery of antibodies and other biologic drugs targeting G-protein-coupled receptors (GPCRs) to develop novel... | TECX competitors |
| Neurogene Inc (NGNE) | Neurogene Inc. is an innovative biotechnology company at the forefront of developing advanced gene therapies for rare neurological disorders... | NGNE competitors |
| Zevra Therapeutics Inc. (ZVRA) | Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions... | ZVRA competitors |
| Ovid Therapeutics Inc (OVID) | Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. | OVID competitors |
| PepGen Ltd (PEPG) | PepGen Inc., a clinical-stage biotechnology company, is focused on the development of oligonucleotide therapeutics for use in the treatment of serious... | PEPG competitors |
| Prothena Corporation plc (PRTA) | Prothena Corporation plc, an advanced stage clinical company, is focused on the discovery and development of new therapies for life-threatening diseases... | PRTA competitors |
| Inovio Pharmaceuticals Inc (INO) | Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development... | INO competitors |
| Kyverna Therapeutics, Inc. Common Stock (KYTX) | Kyverna Therapeutics, Inc. is an innovative biotechnology company focused on advancing immunotherapies for autoimmune diseases and other significant health... | KYTX competitors |
| Candel Therapeutics Inc (CADL) | Candel Therapeutics Inc. is a pioneering biotechnology company focused on revolutionizing cancer treatment through its proprietary oncolytic virus platform... | CADL competitors |
| Entera Bio Ltd (ENTX) | Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally administered large molecule therapies... | ENTX competitors |
| Precision BioSciences Inc (DTIL) | Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. | DTIL competitors |
Frequently Asked Questions About TVGN
Who are Tevogen Bio Holdings' main competitors?
The companies most similar to Tevogen Bio Holdings include Regenxbio (RGNX), Tectonic Therapeutic (TECX), Neurogene (NGNE), Zevra Therapeutics (ZVRA) and Ovid Therapeutics (OVID), listed from the closest match.
Who is Tevogen Bio Holdings' biggest competitor?
Entera Bio (ENTX) is the largest of the similar companies at $541.57M; Regenxbio (RGNX) is the closest match by business profile, size, sector and industry.
How does TVGN stock compare with its competitors?
TVGN's net margin is 0.0% against a peer median of 0.0%.
Which of Tevogen Bio Holdings' competitors pays a higher dividend?
Tevogen Bio Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Tevogen Bio Holdings bigger than its competitors?
No. Tevogen Bio Holdings is 10th by market cap among the 13 companies on this page; the largest is Entera Bio (ENTX) at $541.57M.
TVGN pages: Overview, Forecast, Financials, Competitors